We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Blood Substitute Shows Promise in Emergency Care

By HospiMedica staff writers
Posted on 15 Dec 2003
A synthetic blood product has demonstrated great potential in clinical trials, with no signs of the rejection or other harmful side effects seen with earlier blood substitutes, such as hypertension.

The trials also demonstrated that the synthetic blood carried even more oxygen throughout the body than genuine blood, which can help limit the tissue damage associated with oxygen deprivation. More...
The new hemoglobin, intended for transfusion, is taken from "old” red blood cells in donated supplies. The method was developed by Dr. Seetharama Acharya, professor of medicine and biophysics and physiology at Albert Einstein College of Medicine (New York, NY, USA).

"With our blood product, the issue of blood typing is removed,” said Dr. Acharya. "Patients with any blood type can receive the artificial blood, which then transports oxygen through the body to help limit damage at a time when loss of blood can lead to death.”

Eliminating the need for blood typing can save critical seconds, for example, in emergency situations or on the battlefield. Early trials are now underway at Karolinska Hospital (Stockholm, Sweden). To date, eight patients have been tested, with none showing signs either of rejection or other side effects. The scientists working on the project are also fine-tuning a powdered form of the substitute that can be reconstituted for use by simply adding water.




Related Links:
Albert Einstein College

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.